Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial.
Front Med
; 15(5): 704-717, 2021 Oct.
Article
in En
| MEDLINE
| ID: mdl-33909260
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Front Med
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: